systemic lupus erythematosus therapeutic (SATT CONECTUS ALSACE)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug Namesystemic lupus erythematosus therapeutic (SATT CONECTUS ALSACE)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsLupus Erythematosus, Systemic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSATT Conectus

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesSATT Conectus

Active IndicationsN/A

Inactive IndicationsLupus Erythematosus, Systemic

ATC CodeN/A